Key result
Among 369 dogs with dilated cardiomyopathy, the median survival time was 19 weeks, with 65% presenting in stage 3 heart failure and 89% having an arrhythmia at presentation.
Observational (n=369)
Canine dilated cardiomyopathy primarily affects medium to large pure-bred male dogs, often presenting late with a short clinical phase and poor survival.
Answers are grounded in this paper and cite their sources.
Suggests guarded prognosis with late-stage canine DCM; leaves open whether earlier detection improves outcomes in at-risk breeds.
OBJECTIVE: To review the clinical and diagnostic findings and survival of dilated cardiomyopathy from a large population of dogs in England. METHODS: A retrospective study of the case records of dogs with dilated cardiomyopathy collected between January 1993 and May 2006. RESULTS: There were 369 dogs with dilated cardiomyopathy of which all were pure-bred dogs except for four. The most commonly affected breeds were dobermanns and boxers. Over 95 per cent of dogs weighed more than 15 kg and 73 per cent were male. The median duration of signs before referral was three weeks with 65 per cent presenting in stage 3 heart failure. The most common signs were breathlessness (67 per cent) and coughing (64 per cent). The majority of dogs (89 per cent) had an arrhythmia at presentation and 74 per cent of dogs had radiographic signs of pulmonary oedema or pleural effusion. The median survival time was 19 weeks. CLINICAL SIGNIFICANCE: Dilated cardiomyopathy occurs primarily in medium to large breed pure-bred dogs, and males are more frequently affected than females. The duration of clinical signs before referral is often short and the survival times are poor. Greater awareness of affected breeds, clinical signs and diagnostic findings may help in early recognition of this disease which often has a short clinical phase.
No takes yet. Share an insight, caveat, or question.
Martin et al. (2008) conducted an observational in Canine dilated cardiomyopathy (n=369). Dilated cardiomyopathy was evaluated on Survival time. Among 369 dogs with dilated cardiomyopathy, the median survival time was 19 weeks, with 65% presenting in stage 3 heart failure and 89% having an arrhythmia at presentation.
Synapse has enriched 10 related papers. Consider them for comparative context: